Strontium-82 and Future Germanium-68 Production at the ARRONAX Facility

Sounalet, Thomas; Michel, Nathalie; Alliot, Cyrille; Audouin, A.; Barbet, Jacques; Bonraisin, A.C.; Bortoli, Y.; Bosse, Valérie; Bourdeau, C.; Bouvet, G.; Buhour, J.M.; Cadiou, Anne; Fresneau, S.; Guillamet, M.; Haddad, Férid; Laizé, J.; Milleto, T.; Milon, F.; Mokili, M.; Montavon, Gilles

doi:10.1016/j.nds.2014.08.072

Cited by 4 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This requires a robust and complex solid target design that can handle a high heat transfer for prolonged periods, as well as reliable purification of the material once the irradiation is complete. The rising need for 68 Ga radionuclide fuels developments in this area (Fitzsimmons and Mausner, 2015a ; Fitzsimmons and Mausner, 2015b ; Sounalet et al, 2014 ; Bach et al, 2013 ).…”

Section: Developments In Radionuclide Productionmentioning

confidence: 99%

Production of novel diagnostic radionuclides in small medical cyclotrons

Synowiecki

Perk

Nijsen

2018

EJNMMI radiopharm. chem.

View full text Add to dashboard Cite

The global network of cyclotrons has expanded rapidly over the last decade. The bulk of its industrial potential is composed of small medical cyclotrons with a proton energy below 20 MeV for radionuclides production. This review focuses on the recent developments of novel medical radionuclides produced by cyclotrons in the energy range of 3 MeV to 20 MeV. The production of the following medical radionuclides will be described based on available literature sources: Tc-99 m, I-123, I-124, Zr-89, Cu-64, Ga-67, Ga-68, In-111, Y-86 and Sc-44. Remarkable developments in the production process have been observed in only some cases. More research is needed to make novel radionuclide cyclotron production available for the medical industry.

show abstract